Home Impurity Dabigatran CS-O-14210

Dabigatran Impurity C

Impurity API Family: Dabigatran CAT No. CS-O-14210 CAS No. 1610758-20-7
In Stock
Product Detail

Dabigatran Impurity C

Dabigatran Impurity
Stock Status: In Stock  Login to view price
Live
For Research & Analytical Purposes. Not for Personal use.
Category Impurity
API Family Dabigatran
Storage Store at refrigerator (2-8°C) for long term storage
Hazard Information Refer MSDS for accurate information.

Dabigatran Impurity C Product Information

Dabigatran Impurity C is listed under Impurity. It is associated with Dabigatran and is intended for analytical research, quality control and pharmaceutical reference standard applications. The product is supplied by Clearsynth under CAT No. CS-O-14210.

Clearsynth provides this compound for research and analytical use, with product information including CAS number, molecular formula, molecular weight, stock enquiry details and supporting documentation.

Technical Data

Product Name
Dabigatran Impurity C
CAS No.
1610758-20-7
CAT No.
CS-O-14210
Molecular Formula
C34H41N7O5
Molecular Weight
627.73
Category
API Family
Storage Condition
Store at refrigerator (2-8°C) for long term storage
SMILES
O=C(OCC)CCN(C1=NC=CC=C1)C(C2=CC=C3N(C)C(CNC4=CC=C(C(NC(OCC(CC)CC)=O)=N)C=C4)=NC3=C2)=O
IUPAC Name
ethyl 3-(2-(((4-(N-((2-ethylbutoxy)carbonyl)carbamimidoyl)phenyl)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate
Purity by HPLC
94.13%
Hazard Compound
Refer MSDS for accurate information.

Description

Overview
Useful research chemical for a range of applications.
Synonyms
ethyl 3-(2-(((4-(N-((2-ethylbutoxy)carbonyl)carbamimidoyl)phenyl)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate
Application Notes
Useful research chemical for a range of applications.
References
Downloading MSDS…
Done
Done
RFQ Basket 0
Done
RFQ Basket 0
Quick Enquiry
Tell us what you need
Quote Basket
Selected RFQ Items
Your RFQ basket is empty. Add a product block or copy a guided requirement here.